• Hannah Cole

Latest listings

  • FL83B

    FL83B

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    FL83B is a spontaneously immortalized hepatocyte cell line derived from the liver of a 15 to 17-day-old fetal C57BL/6J mouse. https://www.creative-bioarray.com/fl83b-csc-c7104j-item-49147.htm

  • NH-6

    NH-6

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6326J Description Human cell line derived from neuroblastoma of adrenal gland. Species Homo sapiens (Human) Source Adrenal Gland https://www.creative-bioarray.com/nh-6-item-csc-c6326j-42926.htm

  • BALB/3T3 clone A31

    BALB/3T3 clone A31

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Species: mouse - embryo, 14 to 17 days old, Mus musculus Strain: BALB/c Virus Susceptibility: Herpes simples; vesicular stomatitis (Indiana) Tumorigenecity: no https://www.creative-bioarray.com/BALB-3T3-clone-A31-CSC-C9339L-item-39487.htm

  • Py230

    Py230

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    The Py230 cell line is an epithelial-like murine mammary luminal tumor cell line that has properties similar to those of normal mouse mammary stem cells. It was derived from a mammary adenocarcinoma that spontaneously arose in a MMTV-PyMY (mouse mamm...

  • Py8119

    Py8119

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    The P8119 cell line represents a mesenchymal tumor cell derived from a mammary adenocarcinoma that spontaneously arose in a MMTV-PyMY (mouse mammary tumor virus promoter driven Polyoma middle T-antigen) transgenic C57BL/6 female mouse. This cell line...

  • NMuMG

    NMuMG

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Initiated from the mammary gland tissue of an adult NAMRU mouse and one of a series of epithelial cell lines derived from normal glandular tissue of mice. The cells exhibit many ultrastructural features of secretory epithelium as well as desmosomes o...

  • MS-5

    MS-5

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established by irradiation of the adherent cells in long-term bone marrow cultures derived from C3H/HeNSlc strain mice https://www.creative-bioarray.com/MS-5-CSC-C2763-item-1619.htm

  • NS20Y

    NS20Y

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established from a A/J mouse strain with neuroblastoma C1300; cells were described to be aneuploid and to contain high specific activity of choline acetyltransferase https://www.creative-bioarray.com/NS20Y-CSC-C1062-item-1530.htm

  • A20

    A20

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6292J Description Mouse cell line derived from lymphoma. Species Mus musculus (Mouse) Recommended Medium RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/a20-item-csc-c6292j-42892.htm

  • BA/F3

    BA/F3

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    IL-3 dependent murine pro B cell line; the precise origin of the cell line is unclear; however, performing May-Grünwald-Giemsa staining provides evidence that the cells are indeed from a lymphatic back ground. Cells were apparently not derived from B...